Open-Label Pilot Study of the Efficacy and Safety of Vusion Ointment for the Treatment of Intertrigo

Completed · Early Phase 1

Conditions studied: Intertrigo

In brief

The purpose of this study is to determine if people with moist, red, patches on their skin in body folds would benefit treatment of those areas with an FDA-approved drug called Vusion.

Key facts

Study ID

NCT01118910

Run by

Image Dermatology P.C.

People needed

15

Starts

2010-04-01

Expected to finish

2011-05-01

Last updated by the study team

2011-08-04

Who can join

Age: 12 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Evidence of intertrigo

You may not qualify if…

• Pregnancy
• Use of systemic or topical antifungal or corticosteroid treatment in the previous 14 days or during the 3-month treatment period
• allergy of sensitivity to Vusion
• undergoing warfarin anticoagulation
• alcohol or drug abuse
• Investigator determines they cannot particpate
• history of non-compliance or poor cooperation
• participation in an investigaitonal drug study within 30 days of Baseline Visit

Where it is running

• Image Dermatology P.C. — Montclair, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.